Search Results - "Jokaji, Hiroshi"

Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats by Yamazaki, M, Asakura, H, Aoshima, K, Saito, M, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Ikeda, T, Matsuda, T

“…We investigated the protective effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against two kinds of experimental…”
Get more information

Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats by Yamazaki, M, Asakura, H, Aoshima, K, Saito, M, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Ikeda, T, Matsuda, T

“…We investigated the protective effects of DX-9065a, an orally active, newly synthesized, and specific inhibitor of factor Xa, against experimental disseminated…”
Get more information

Hyperlipidemia and hemostatic system by Morishita, E, Jokaji, H, Matsuda, T

“…The plasma levels of blood coagulation and fibrinolytic factors and the serum levels of lipids were measured in 62 subjects (22 normolipidemia and 40…”
Get more information

Changes in hemostatic and fibrinolytic proteins in patients receiving L-asparaginase therapy by Saito, M, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Ito, K, Matsuda, T

“…Hemostatic changes were evaluated in ten patients with acute lymphoblastic leukemia and lymphoma who received chemotherapy with L-asparaginase, vincristine,…”
Get more information

Prothrombin Himi; an abnormal prothrombin characterized by a defective thrombin activity by Morishita, E, Saito, M, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Yamazaki, M, Hachiya, H, Okamura, M, Matsuda, T

“…An abnormal prothrombin has been detected in a 26-year-old female, who had no history of excessive bleeding. Prothrombin activity was approximately 10% when…”
Get more information

Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM) by Jokaji, H, Asakura, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

“…Parameters of fibrinolysis, including plasminogen, alpha 2 plasmin-inhibitor (alpha 2 PI), tissue-type plasminogen activator (t-PA) and plasminogen activator…”
Get more information

Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases by Saito, M, Morishita, E, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Yamazaki, M, Aoshima, K, Matsuda, T

“…We measured plasma levels of tissue factor (TF), total tissue factor pathway inhibitor (TFPI) and free TFPI antigen in patients with diabetes mellitus (DM),…”
Get more information

Mechanism on disorders of coagulation and fibrinolysis in diabetes by MATSUDA, T, MORISHITA, E, JOKAJI, H, ASAKURA, H, SAITO, M, YOSHIDA, T, TAKEMOTO, K.-I

“…Determination of various important parameters of coagulation and fibrinolysis, clinical characteristics, and levels of serum lipid were compared in 193…”
Get full text

Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus by Morishita, Eriko, Asakura, Hidesaku, Jokaji, Hiroshi, Saito, Masanori, Uotani, Chika, Kumabashiri, Ichiro, Yamazaki, Masahide, Aoshima, Keiji, Hashimoto, Takuma, Matsuda, Tamotsu

“…Diabetes mellitus is associated with disturbances in hemostasis that could contribute to the development of diabetic vascular disease. We investigated the…”
Get full text

Hypercoagulability during the recovery period of leukocyte count after chemotherapy by Saito, M, Asakura, H, Uotani, C, Jokaji, H, Kumabashiri, I, Matsuda, T

Get more information

Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome by Yamazaki, M, Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Aoshima, K, Ikeda, T, Matsuda, T

“…The mechanisms underlying clinical abnormalities associated with the antiphospholipid antibody syndrome (APAS) have not been elucidated. We measured plasma…”
Get more information

Mechanism on disorders of coagulation and fibrinolysis in diabetes by Matsuda, Tamotsu, Morishita, Eriko, Jokaji, Hiroshi, Asakura, Hidesaku, Saito, Masanori, Yoshida, Tomotaka, Takemoto, Ken-ichi

Get full text

Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

“…We examined the changes in plasma levels of soluble thrombomodulin in 66 cases of disseminated intravascular coagulation (DIC), to investigate the damage to…”
Get more information

Prothrombin Fragment 1 +2 Measures Treatment Effect in Patients with Antiphospholipid Syndrome by Yamazaki, Masahide, Asakura, Hidesaku, Saito, Masanori, Jokaji, Hiroshi, Uotani, Chika, Kumabashiri, Ichiro, Morishita, Eriko, Aoshima, Keiji, Matsuda, Tamotsu, Triplett, Douglas A.

“…Antiphospholipid syndrome (APS) is characterized by recurrent thrombosis. The anticoagulant management of APS thrombosis remains controversial. Few reports on…”
Get full text

Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation by Asakura, H, Jokaji, H, Saito, M, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Matsuda, T

“…Plasma levels of tissue-plasminogen activator.plasminogen activator inhibitor (t-PA.PAI) complex and active PAI were assayed in 58 cases of disseminated…”
Get more information

Increased levels of plasma thrombomodulin in chronic myelogenous leukemia by Morishita, E, Saito, M, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Yamazaki, M, Matsuda, T

“…Circulating blood plasma contains proteinase-degraded forms of thrombomodulin that are soluble. We quantitatively assayed the plasma levels of thrombomodulin…”
Get more information

Levels of Activated Factor VII in Patients With Disseminated Intravascular Coagulation by Saito, Masanori, Asakura, Hidesaku, Yoshida, Tomotaka, Jokaji, Hiroshi, Uotani, Chika, Kumabashiri, Ichiro, Morishita, Eriko, Yamazaki, Masahide, Aoshima, Keiji, Matsuda, Tamotsu

Get full text

Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis by Saito, M, Asakura, H, Jokaji, H, Uotani, C, Kumabashiri, I, Morishita, E, Yamazaki, M, Yoshida, T, Aoshima, K, Matsuda, T

“…Induction of leukocytopenia by cytotoxic drugs protects against the generalized Shwartzman reaction induced by endotoxin. To elucidate the relationship between…”
Get more information

The levels of protein C and protein S in plasma in patients with type II diabetes mellitus by Saito, M, Kumabashiri, I, Jokaji, H, Asakura, H, Uotani, C, Otsuka, M, Hamada, M, Tatsumura, M, Morinaga, K, Matsuda, T

Get more information

Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia by Saito, M, Asakura, H, Jokaji, H, Uotanzi, C, Kumabashiri, I, Yoshida, T, Hashizume, K, Matsuda, T

“…We quantitatively assayed the levels of cross-linked fibrin degradation products (D dimer) in plasma at 73 points in time in 32 patients with elevated…”
Get more information